Milgamma Na (Benfotiamine, Pyridoxine Hydrochloride)

Benfotiamine, the active ingredient in Milgamma Na, is a nutrition supplement presented as an oral dosage form for oral use. It is combined with pyridoxine hydrochloride to support metabolic and nerve health in adults. GNH USA supplies Milgamma Na as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Milgamma Na contains benfotiamine and pyridoxine, nutrients that act on peripheral nerve function and vitamin B6 metabolism. - Diabetic neuropathy: supports nerve health and may lessen tingling, burning or pain associated with diabetes. - Peripheral nerve disorders: contributes to the maintenance of normal nerve conduction and reduces discomfort in various neuropathic conditions. - Vitamin B6 deficiency: provides pyridoxine to correct low levels and alleviate related neurological symptoms.

Milgamma Na is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Nausea: mild stomach upset after ingestion. - Abdominal discomfort: occasional cramping or bloating. - Headache: transient mild headache. - Dizziness: light‑headed feeling, usually brief. - Skin rash: mild erythema or itching at the site of contact. - Taste alteration: temporary change in taste perception.

Serious or Rare Side Effects: - Hypersensitivity reaction: swelling, hives, or difficulty breathing. - Severe skin reaction: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylaxis: rapid onset of severe allergic response. - Liver enzyme elevation: abnormal liver function tests. - Hematologic abnormalities: rare cases of leukopenia or thrombocytopenia.

Before using Milgamma Na, consider the following safety measures. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: use only if advised by a physician. - Renal impairment: monitor kidney function and adjust use if necessary. - Drug interactions: review all concomitant medications with a pharmacist. - Allergy: avoid if known hypersensitivity to benfotiamine, pyridoxine, or excipients. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct light.

Milgamma Na may interact with certain medicines; assess potential risks.

Major Interactions (Avoid): - Levodopa: high‑dose pyridoxine may reduce levodopa efficacy. - Chemotherapy agents (e.g., cisplatin): benfotiamine could interfere with drug activity.

Moderate Interactions (Monitor Closely): - Antihypertensive drugs: pyridoxine may enhance blood‑pressure‑lowering effects. - Statins: benfotiamine might affect lipid metabolism, requiring monitoring. - Alcohol: excessive intake can increase risk of peripheral neuropathy. - Antidiabetic medications: monitor glucose control when adding benfotiamine.